Bionomics' BNC210 Clinical Trial Results Confirm Safety and Indicate Reduced Stress Hormone Levels
BNC210 reduced blood levels of stress hormone in trial subjects, indicating anxiolytic activity
04-Mar-2010 -
Bionomics Limited announced the final results of its Phase Ia clinical trial of BNC210. Dosing of healthy male volunteers in stage 2 of the Phase Ia trial, which was conducted at the Pain and Anaesthesia Research Clinic (PARC) within the Royal Adelaide Hospital, was completed on schedule at the ...
absorption
anaesthesia
anxiety
+7